Literature DB >> 12675914

SKF83959 selectively regulates phosphatidylinositol-linked D1 dopamine receptors in rat brain.

Li-Qing Jin1, Satindra Goswami, Guoping Cai, Xuechu Zhen, Eitan Friedman.   

Abstract

Previously a distinct D1-like dopamine receptor (DAR) that selectively couples to phospholipase C/phosphatidylinositol (PLC/PI) was proposed. However, lack of a selective agonist has limited efforts aimed at characterizing this receptor. We characterized the in vitro and in vivo effects of SKF83959 in regulating PI metabolism. SKF83959 stimulates (EC50, 8 micro m) phosphatidylinositol 4,5-biphosphate hydrolysis in membranes of frontal cortex (FC) but not in membranes from PC12 cells expressing classical D1A DARs. Stimulation of FC PI metabolism was attenuated by the D1 antagonist, SCH23390, indicating that SKF83959 activates a D1-like DAR. The PI-linked DAR is located in hippocampus, cerebellum, striatum and FC. Most significantly, administration of SKF83959 induced accumulations of IP3 in striatum and hippocampus. In contrast to other D1 DAR agonists, SKF83959 did not increase cAMP production in brain or in D1A DAR-expressing PC12 cell membranes. However, SKF83959 inhibited cAMP elevation elicited by the D1A DAR agonist, SKF81297, indicating that the compound is an antagonist of the classical D1A DAR. Lastly, we demonstrated that SKF83959 enhances [35S]guanosine 5'-O-(3-thiotriphosphate) binding to membrane Galphaq and Galphai proteins, suggesting that PI stimulation is mediated by activation of these guanine nucleotide-binding regulatory proteins. Results indicate that SKF83959 is a selective agonist for the PI-linked D1-like DAR, providing a unique tool for investigating the functions of this brain D1 DAR subtype.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12675914     DOI: 10.1046/j.1471-4159.2003.01698.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  52 in total

1.  Inhibitory effects of dopamine on spinal synaptic transmission via dopamine D1-like receptors in neonatal rats.

Authors:  K Kawamoto; K Otsuguro; M Ishizuka; S Ito
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Enhanced brain-derived neurotrophic factor signaling in the nucleus accumbens of juvenile rats.

Authors:  Melissa L Perreault; Theresa Fan; Brian F O'Dowd; Susan R George
Journal:  Dev Neurosci       Date:  2013-09-07       Impact factor: 2.984

Review 3.  Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface.

Authors:  John L Waddington; Colm O'Tuathaigh; Gerard O'Sullivan; Katsunori Tomiyama; Noriaki Koshikawa; David T Croke
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

4.  D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum.

Authors:  Asim J Rashid; Christopher H So; Michael M C Kong; Teresa Furtak; Mufida El-Ghundi; Regina Cheng; Brian F O'Dowd; Susan R George
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-28       Impact factor: 11.205

5.  Rotation and immediate-early gene expression in rats treated with the atypical D1 dopamine agonist SKF 83822.

Authors:  David Wirtshafter
Journal:  Pharmacol Biochem Behav       Date:  2007-01-20       Impact factor: 3.533

6.  Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor.

Authors:  Jennie L Conroy; R Benjamin Free; David R Sibley
Journal:  ACS Chem Neurosci       Date:  2015-02-20       Impact factor: 4.418

7.  Perinatal n-3 fatty acid deficiency selectively reduces myo-inositol levels in the adult rat PFC: an in vivo (1)H-MRS study.

Authors:  Robert K McNamara; Jessica Able; Ronald Jandacek; Therese Rider; Patrick Tso; Diana M Lindquist
Journal:  J Lipid Res       Date:  2008-09-18       Impact factor: 5.922

8.  Electrophysiological effects of SKF83959 on hippocampal CA1 pyramidal neurons: potential mechanisms for the drug's neuroprotective effects.

Authors:  Hong-Yuan Chu; Qinhua Gu; Guo-Zhang Jin; Guo-Yuan Hu; Xuechu Zhen
Journal:  PLoS One       Date:  2010-10-01       Impact factor: 3.240

Review 9.  Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction.

Authors:  Patricia S Goldman-Rakic; Stacy A Castner; Torgny H Svensson; Larry J Siever; Graham V Williams
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

10.  D5 dopamine receptors are required for dopaminergic activation of phospholipase C.

Authors:  Asha Sahu; Kimberly R Tyeryar; Habiba O Vongtau; David R Sibley; Ashiwel S Undieh
Journal:  Mol Pharmacol       Date:  2008-12-01       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.